QCM
MIRM icon

Quantinno Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Quantinno Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.14M Buy
18,245
+9,748
+115% +$979K ﹤0.01% 1917
2026
Q1 		$785K Buy
8,497
+5,305
+166% +$499K ﹤0.01% 2375
2025
Q4 		$252K Buy
3,192
+449
+16% +$32.2K ﹤0.01% 2936
2025
Q3 		$201K Buy
+2,743
New +$174K ﹤0.01% 2763

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantinno Capital Management's MIRM Position: Q2 2026 in Review

Quantinno Capital Management increased its Mirum Pharmaceuticals (MIRM) stake by 115% in Q2 2026, buying an estimated $979K and bringing the position to 18,245 shares worth $2.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1917.

Quantinno Capital Management first reported a position in MIRM in Q3 2025 and has held it in 4 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Quantinno Capital Management held 18,245 shares of Mirum Pharmaceuticals worth $2.14M as of Q2 2026.
  • Quantinno Capital Management bought 9,748 Mirum Pharmaceuticals shares in Q2 2026, an estimated $979K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1917 holding.
  • Quantinno Capital Management first reported a position in Mirum Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.